BLOOD PURIFICATION TO TREAT PATIENTS WITH REFRACTORY GLOMERULONEPHRITIS

血液净化治疗难治性肾小球肾炎患者

• 批准号: 3742547
• 负责人: SHARON G ADLER
• 金额: --
• 依托单位: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3742547
• 关键词: adsorption; blood treatment; glomerulonephritis; human subject; human therapy evaluation; nephrotic syndrome; plasmapheresis; renal failure

Patients with glomerulonephritis that is unresponsive to standard therapy will be treated with plasmapheresis or immunoadsorption in order to induce remission of nephrotic syndrome and prevention of progressive kidney failure.

对标准治疗无效的肾小球肾炎患者 将接受血浆置换或免疫吸附治疗，以便 诱导肾病综合征缓解与预防进展期 肾衰竭。